Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation

Although venetoclax-based lower-intensity regimens have greatly improved outcomes for older adults with acute myeloid leukemia (AML) who are unfit for intensive chemotherapy, the optimal induction for older patients with newly diagnosed AML who are suitable candidates for hematopoietic stem cell tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Short, Nicholas J., Ong, Faustine, Ravandi, Farhad, Nogueras-Gonzalez, Graciela, Kadia, Tapan M., Daver, Naval, DiNardo, Courtney D., Konopleva, Marina, Borthakur, Gautam, Oran, Betul, Al-Atrash, Gheath, Mehta, Rohtesh, Jabbour, Elias J., Yilmaz, Musa, Issa, Ghayas C, Maiti, Abhishek, Champlin, Richard E, Kantarjian, Hagop, Shpall, Elizabeth J, Popat, Uday
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Myeloid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368841/
https://www.ncbi.nlm.nih.gov/pubmed/37104058
http://dx.doi.org/10.1182/bloodadvances.2022009632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368841/
https://www.ncbi.nlm.nih.gov/pubmed/37104058
http://dx.doi.org/10.1182/bloodadvances.2022009632

Ejemplares similares